DADC
AGN

D.A. Davidson & Co’s Allergan plc AGN Stock Holding History

D.A. Davidson & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,473
Closed -$969K – 1043
2020
Q1 		$969K Sell
5,473
-443
-7% -$83.4K 0.02% 447
2019
Q4 		$1.13M Sell
5,916
-312
-5% -$56.3K 0.02% 473
2019
Q3 		$1.05M Sell
6,228
-121
-2% -$19.7K 0.02% 462
2019
Q2 		$1.06M Sell
6,349
-34,217
-84% -$4.74M 0.02% 459
2019
Q1 		$5.92M Buy
40,566
+13,364
+49% +$1.94M 0.1% 155
2018
Q4 		$3.64M Sell
27,202
-19,257
-41% -$3.16M 0.07% 219
2018
Q3 		$8.85M Buy
46,459
+740
+2% +$136K 0.16% 110
2018
Q2 		$7.62M Sell
45,719
-252
-0.5% -$40.5K 0.15% 118
2018
Q1 		$7.74M Buy
45,971
+13,276
+41% +$2.23M 0.16% 111
2017
Q4 		$5.35M Sell
32,695
-8,431
-21% -$1.51M 0.11% 153
2017
Q3 		$8.43M Buy
41,126
+1,412
+4% +$328K 0.17% 138
2017
Q2 		$9.65M Sell
39,714
-282
-0.7% -$66.3K 0.22% 81
2017
Q1 		$9.55M Sell
39,996
-6,898
-15% -$1.61M 0.23% 80
2016
Q4 		$9.84M Buy
46,894
+2,463
+6% +$510K 0.22% 92
2016
Q3 		$10.2M Buy
44,431
+6,064
+16% +$1.48M 0.25% 80
2016
Q2 		$8.86M Buy
38,367
+19,403
+102% +$4.47M 0.26% 78
2016
Q1 		$5.08M Buy
18,964
+464
+3% +$133K 0.16% 130
2015
Q4 		$5.78M Sell
18,500
-1,963
-10% -$584K 0.19% 115
2015
Q3 		$5.56M Sell
20,463
-693
-3% -$213K 0.19% 109
2015
Q2 		$6.42M Sell
21,156
-139
-0.7% -$41.5K 0.21% 100
2015
Q1 		$6.33M Sell
21,295
-856
-4% -$244K 0.21% 101
2014
Q4 		$5.7M Buy
22,151
+570
+3% +$142K 0.19% 109
2014
Q3 		$5.21M Buy
21,581
+16,225
+303% +$3.63M 0.18% 112
2014
Q2 		$1.19M Buy
5,356
+939
+21% +$194K 0.04% 387
2014
Q1 		$907K Buy
4,417
+3,581
+428% +$709K 0.03% 434
2013
Q4 		$138K Buy
836
+831
+16,620% +$130K 0.01% 960
2013
Q3 		$0 Hold
5
– – ﹤0.01% 1809
2013
Q2 		$0 Buy
+5
New +$566 ﹤0.01% 1737

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

D.A. Davidson & Co's AGN Position: Q2 2020 in Review

D.A. Davidson & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,473 shares — an estimated $969K sold.

D.A. Davidson & Co first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $10.2M in Q3 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • D.A. Davidson & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • D.A. Davidson & Co sold 5,473 Allergan plc shares in Q2 2020, an estimated $969K.
  • D.A. Davidson & Co first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • D.A. Davidson & Co's Allergan plc position peaked at $10.2M in Q3 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on D.A. Davidson & Co's 13F filing for Q2 2020, filed 10 Aug 2020.